Transthyretin amyloid cardiomyopathy (ATTR-CM) is an under-recognized cause of heart
failure (HF) in older adults, resulting from myocardial deposition of misfolded transthyretin …

Aims An algorithm for non‐invasive diagnosis of amyloid transthyretin cardiac amyloidosis
(ATTR‐CA) and novel disease‐modifying therapies have prompted an active search for CA …

Background Older patients with severe aortic stenosis (AS) are increasingly identified as
having cardiac amyloidosis (CA). It is unknown whether concomitant AS-CA has worse …

Cardiomyopathy is a manifestation of transthyretin amyloidosis (ATTR), which is an
underrecognized systemic disease whereby the transthyretin protein misfolds to form fibrils …

Sharmila Dorbala, MD, MPH, FASNC, Chair*; Yukio Ando, MD, PhD†; Sabahat Bokhari,
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …

Aims Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous clinical
syndrome with multiple underlying causes. Wild-type transthyretin (TTR) amyloidosis …

Background: Transthyretin amyloidosis (ATTR) is a heterogeneous disorder with multiorgan
involvement and a genetic or nongenetic basis. Objectives: The goal of this study was to …

Aims Wild-type transthyretin amyloidosis (ATTRwt) is mostly considered a disease
predominantly of elderly male, characterized by concentric LV hypertrophy, preserved LVEF …

КТИ—кардиоторакальный индекс КШ—коронарное шунтирование ЛЖ—левый
желудочек МНО—международное нормализованное отношение МРТ—магнитно …

Transthyretin amyloidosis is a fatal disorder that is characterized primarily by progressive
neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant …